{"id":119505,"date":"2024-08-22T18:46:17","date_gmt":"2024-08-22T18:46:17","guid":{"rendered":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/08\/22\/lecanemab-bittersweet-moment-for-alzheimers-patients-but-hope-of-treatment-is-still-possible\/"},"modified":"2024-08-22T18:46:18","modified_gmt":"2024-08-22T18:46:18","slug":"lecanemab-bittersweet-moment-for-alzheimers-patients-but-hope-of-treatment-is-still-possible","status":"publish","type":"post","link":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/08\/22\/lecanemab-bittersweet-moment-for-alzheimers-patients-but-hope-of-treatment-is-still-possible\/","title":{"rendered":"Lecanemab: Bittersweet moment for Alzheimer&#8217;s patients &#8211; but hope of treatment is still possible"},"content":{"rendered":"<div style=\"text-align:center\"><img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\/\/i0.wp.com\/e3.365dm.com\/24\/07\/768x432\/skynews-alzheimers-study_6625101.jpg?20240712204409&amp;resize=768,432&amp;ssl=1\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Lecanemab: Bittersweet moment for Alzheimer&#8217;s patients &#8211; but hope of treatment is still possible\" title=\"Lecanemab: Bittersweet moment for Alzheimer&#8217;s patients &#8211; but hope of treatment is still possible\" \/><\/div><p> <br \/>\n<\/p>\n<div data-component-name=\"ui-article-body\" data-highlight-intro=\"true\">\n<p>This is a bittersweet moment for people living with Alzheimer&#8217;s disease and their families.<\/p>\n<p>Hopes had been high that for the first time they would have <strong><a href=\"https:\/\/news.sky.com\/story\/alzheimers-drug-lecanemab-that-slows-decline-given-green-light-in-uk-but-wont-be-available-on-nhs-13200880\" target=\"_blank\" rel=\"noopener\">access to a treatment<\/a><\/strong> that could slow the decline in memory and thinking.<\/p>\n<p>When a pivotal clinical trial was released last year doctors hailed lecanemab as a game-changer, one that could delay the need for care and give families more time together.<\/p>\n<p>But while the medicine&#8217;s regulator has agreed that the drug can be prescribed, the NHS spending watchdog has ruled in draft guidance that it is too expensive to justify the benefits.<\/p>\n<p>Unusually that isn&#8217;t just because of the cost of the drug.<\/p>\n<p>It&#8217;s also the resource implications for the <strong><a href=\"https:\/\/news.sky.com\/topic\/nhs-5893\" target=\"_blank\" rel=\"noopener\">NHS<\/a><\/strong> of organising fortnightly infusions for so many people. And then there is the careful diagnosis and intensive monitoring that is needed to keep patients safe.<\/p>\n<p>Lecanemab is a potent drug. It clears the clumps of abnormal protein called amyloid that build up in the brains of people with Alzheimer&#8217;s.<\/p>\n<div class=\"sdc-article-widget sdc-article-image\">\n<figure class=\"sdc-article-image__figure\">\n<div class=\"sdc-article-image__wrapper\" data-aspect-ratio=\"16\/9\"><\/div><figcaption class=\"ui-media-caption\">\n        <span class=\"u-hide-visually\">Image:<\/span><br \/>\n        <span class=\"ui-media-caption__caption-text\">Lecanemab is a potent drug that can cause dangerous brain swelling<br \/>\n        <\/span><br \/>\n      <\/figcaption><\/figure>\n<\/div>\n<p>But in doing so it can sometimes cause dangerous swelling and bleeding in the brain.<\/p>\n<p>So doctors need to be sure patients really have Alzheimer&#8217;s before they start treatment.<\/p>\n<p>That can only be done at the moment with expensive PET brain scans or samples of spinal fluid &#8211; and the NHS doesn&#8217;t have enough of the right machines or staff.<\/p>\n<p>And patients also need regular checks with an MRI scanner to check there are no side effects in the brain.<\/p>\n<p>All in all, the National Institute for Health and Care Excellence (NICE) said it wasn&#8217;t worth all the resources just to delay the slide from mild to moderate disease by about four to six months.<\/p>\n<p><strong>Read more:<\/strong><br \/><strong><a href=\"https:\/\/news.sky.com\/story\/new-ai-tool-could-be-game-changer-in-battle-against-alzheimers-13177240\" target=\"_blank\" rel=\"noopener\">New AI tool could be game-changer in battle against Alzheimer&#8217;s<\/a><\/strong><br \/><strong><a href=\"https:\/\/news.sky.com\/story\/five-alzheimers-patients-developed-disease-from-decades-old-medical-treatment-doctors-find-13059381\" target=\"_blank\" rel=\"noopener\">Five patients developed Alzheimer&#8217;s from treatment, doctors find<\/a><\/strong><\/p>\n<p>The decision applies to England &#8211; Wales and Northern Ireland often follow that lead. Scotland&#8217;s spending watchdog has yet to make a decision.<\/p>\n<p>So where does this leave patients?<\/p>\n<p>Those who have the funds will be able to pay for private care. In the US that&#8217;s upwards of \u00a320,000 a year. It will feel unfair to many that availability is only there for the privileged.<\/p>\n<div class=\"sdc-article-widget sdc-article-strapline sdc-article-strapline--default-layout\" data-component-name=\"sdc-article-strapline\">\n<div class=\"sdc-article-strapline__link\">\n<div class=\"sdc-article-strapline__image-wrap\">\n                <picture><source srcset=\"https:\/\/e3.365dm.com\/24\/03\/320x180\/skynews-gfxwhatsapppromo-gfxwhatsapp_6490206.png 320w, https:\/\/e3.365dm.com\/24\/03\/640x380\/skynews-gfxwhatsapppromo-gfxwhatsapp_6490206.png 640w\" media=\"(max-width: 480px)\"><source srcset=\"https:\/\/e3.365dm.com\/24\/03\/256x256\/skynews-gfxwhatsapppromo-gfxwhatsapp_6490206.png 256w, https:\/\/e3.365dm.com\/24\/03\/512x512\/skynews-gfxwhatsapppromo-gfxwhatsapp_6490206.png 512w\" media=\"(min-width: 481px)\"><img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/e3.365dm.com\/24\/03\/512x512\/skynews-gfxwhatsapppromo-gfxwhatsapp_6490206.png\" alt=\"Follow Sky News on WhatsApp\" class=\"sdc-article-strapline__image\"\/><br \/>\n                <\/source><\/source><\/picture>\n            <\/div>\n<div class=\"sdc-article-strapline__body\">\n                <span class=\"sdc-article-strapline__title\">Follow Sky News on WhatsApp<\/span><\/p>\n<p class=\"sdc-article-strapline__text\">Keep up with all the latest news from the UK and around the world by following Sky News<\/p>\n<p>                <a href=\"https:\/\/whatsapp.com\/channel\/0029Va868Fv8vd1UsF99tP1u\" class=\"sdc-article-strapline__button\" target=\"_blank\" rel=\"noopener\">Tap here<\/a>\n        <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<p>But some doctors argue that although the drug was a milestone &#8211; the first to have an effect &#8211; the effect was relatively modest.<\/p>\n<p>A healthy lifestyle can also slow the progress of the disease &#8211; a good diet, lots of exercise, not smoking and maintaining social connections are really important.<\/p>\n<p>Decades of research are beginning to pay dividends. Lecanemab is the first of many drugs coming down the tracks. Each will have to be judged on its merits.<\/p>\n<p>But sometime soon it will be possible to give people the hope of treatment.<\/p>\n<\/p><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/news.sky.com\/story\/lecanemab-bittersweet-moment-for-alzheimers-patients-but-hope-of-treatment-is-still-possible-13201275\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This is a bittersweet moment for people living with Alzheimer&#8217;s disease and their families. Hopes had been high that for the first time they would have access to a treatment that could slow the decline in memory and thinking. When a pivotal clinical trial was released last year doctors hailed lecanemab as a game-changer, one [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":119506,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","fifu_image_url":"https:\/\/e3.365dm.com\/24\/07\/768x432\/skynews-alzheimers-study_6625101.jpg?20240712204409","fifu_image_alt":"","footnotes":""},"categories":[607],"tags":[5174,17447,5066,97176,5794,9164,7146],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/119505"}],"collection":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/comments?post=119505"}],"version-history":[{"count":1,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/119505\/revisions"}],"predecessor-version":[{"id":119507,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/119505\/revisions\/119507"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media\/119506"}],"wp:attachment":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media?parent=119505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/categories?post=119505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/tags?post=119505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}